Navigation Links
Organovo To List Common Stock On New York Stock Exchange MKT
Date:7/9/2013

SAN DIEGO, July 9, 2013 /PRNewswire/ --  Organovo Holdings, Inc. (OTCQX: ONVO), a biotechnology company focused on delivering breakthrough three-dimensional (3D) bioprinting technology, is pleased to announce that its common shares have been approved to list on the NYSE MKT and will begin trading on the New York Stock Exchange on July 11, 2013.  The Company will continue to trade under the symbol "ONVO" but will withdraw its shares from listing on the OTC QX concurrent with listing its shares on the NYSE MKT, the premier US equities market for listing and trading of small growth companies.

"Trading on the New York Stock Exchange is an important milestone for Organovo and will be valuable to our business and shareholders. Our decision to move to the NYSE MKT was based on a firm belief that the exchange offers the best set of conditions for Organovo's success, and thus the best opportunity to add value for our shareholders," said Keith Murphy, President and CEO of Organovo Holdings, Inc..  "We found NYSE to have made an unparalleled commitment to providing a fertile platform for growth to early stage biotechnology companies, and we look forward to a great future on the exchange."

NYSE MKT is a fully integrated trading venue within the NYSE Euronext community and leverages the NYSE's advanced and innovative market model to offer a premier venue for listing and trading the stocks of small companies.  The venue utilizes the trading, connectivity and routing technologies of the NYSE platform and offers superior price discovery, superior liquidity and reduced trading volatility.  Listed companies benefit from issuer-selected Designated Market Makers (DMM) that utilize world-class NYSE trading systems to discover and improve prices, dampen volatility, add liquidity and enhance value.  In addition, NYSE MKT-listed companies gain access to the brand v
'/>"/>

SOURCE Organovo Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
2. Organovo, Inc. to Webcast, Live, at RetailInvestorConferences.com on March 1st
3. Organovo, Inc. Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
4. Organovo Announces Close of $15.2 Million Private Placement to Advance 3D Bioprinting for Medical Applications
5. Organovo Announces Relocation and Commencement of Operations at Larger Facility
6. Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
7. Organovo To Present At Lazard Healthcare Conference
8. Organovo Reports Q3 2012 Financial Results, Provides Business Update
9. Organovo Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. Organovo Partners With ZenBio to Create 3D Tissue Models
11. Organovo to Present at the 12th Annual Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , Dec. 15, 2014  GlassesOff Inc. (OTCBB: ... Bar-Gil as an independent director of the Company,s ... of AeroScout and served as its CEO until its ... 2012, a $240 million transaction. Recognized as the inventor ... Bar-Gil,s leadership, AeroScout provided Wi-Fi -based RFID solutions focused ...
(Date:12/13/2014)... Rockville, Maryland (PRWEB) December 12, 2014 ... Maryland, today announced its new name: Therabron Therapeutics ... words therapy and bronchioles (a type of structure in ... incorporating the company’s mission to develop novel protein therapeutics ... board of directors decided to change the name to ...
(Date:12/13/2014)... York (PRWEB) December 13, 2014 QuickSTAT ... global network and Cold Chain capabilities, and is delighted ... in Paris, France, to serve Life Science clients in ... equipped with a controlled-ambient warehouse, will provide 24/7 transportation ... vaccines and investigational drugs, patient-clinical specimens, API, following IATA ...
(Date:12/12/2014)... InSphero AG, the world’s leading provider of 3D ... data presented recently by Genentech (South San Francisco, CA) ... model system for assessment of liver toxicity. ... Analysis and Screening Technologies (FAST) Congress summarized a ... 3D InSight™ Human Liver Microtissues to 42 known ...
Breaking Biology Technology:AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2Quick Opens Office in France to Serve Life Science Community In France and Neighboring French-Speaking Countries 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 3
... /Xinhua-PRNewswire-FirstCall/ -- Shengtai,Pharmaceutical, Inc. (OTC Bulletin Board: ... manufacturer and distributor in China of high-,quality, ... industry and,glucose and starch products for food, ... of Ms. Melody Shi as its Chief ...
... May 1 DermAvance Pharmaceuticals, a,privately held ... skin health and cosmetic dermatology, today announced ... Technology Partners of,Southeastern Pennsylvania (BFTP/SEP). These funds ... will be used to complete the acquisition ...
... Cell Therapy Company,s Move Driven by Commitment of Governor and ... Collaboration with Leading Stem Cell Researcher, EWING, N.J., ... its East Coast operations in Ewing, N.J., The move, ... through the New Jersey Economic Development Authority,puts StemCyte,s executives in ...
Cached Biology Technology:Shengtai Pharmaceutical, Inc. Appoints New CFO 2Shengtai Pharmaceutical, Inc. Appoints New CFO 3DermAvance Pharmaceuticals Announces Investment by Ben Franklin Technology Partners of Southeastern Pennsylvania 2StemCyte Locates East Coast Operations in New Jersey 2
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology ... system measures the overall facial feature of a ... the distance between eyes. Facial recognition is used ...
(Date:12/11/2014)...  That blood pressure plays a role in human health ... medical term for high blood pressure – was first described ... cuff that,s used in measuring blood pressure was invented in ... about hypertension, its triggers and its effects. In fact, recent ... the best ways to treat it. For example, ...
(Date:12/10/2014)... Dec. 9, 2014  Valencell, a leader in performance ... a staggering demand from its licensees for highly accurate, ... is not solely coming from fitness and health sectors, ... "A wearable is only as useful as the ... the ultimate driver in long-term mass consumer adoption of ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... ARBOR, Mich. Head and neck cancer patients who smoked, ... were diagnosed had worse survival outcomes than those with better ... of Michigan Comprehensive Cancer Center. "While there has been ... linked to cancer survival, the health habits a person has ...
... University College London Business PLC (UCLB) and Ocera Therapeutics ... of an exclusive worldwide licensing agreement for UCL-L1V and ... the treatment of acute hepatic encephalopathy (AHE). ... blood levels of ammonia, a highly toxic chemical that ...
... honored as the 2009 recipient of the Signature Genomic Laboratories ... 2009 Annual Clinical Genetics Meeting in Tampa, Florida. Dr. ... York General Hospital in Toronto, Canada. Dr. Chun received ... A new award in 2008, the Signature Genomics Travel Award ...
Cached Biology News:Health choices predict cancer survival, U-M study finds 2Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB 2Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB 3
... and SYBR Safe DNA Gel Stain combo offers these ... buying these same products separately ... bromide Eliminates risks to ... and RNA fragments from 100 bp to >30 kb. ...
...
Sterile detoxified 10% bovine serum albumin (BSA) in Iscoves MDM. This BSA has been selected to support the optimal colony growth of human hematopoietic progenitor cells in methylcellulose-based medi...
... A full-featured high-performance ICP-MS system designed for ... interface, Omega II off-axis ion lens, true ... 7500a can handle the widest range of ... the 7500a now includes as standard Agilents ...
Biology Products: